Quantbot Technologies’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-8,553
| Closed | -$1.47M | – | 2079 |
|
|
2021
Q3 | $1.47M | Buy |
+8,553
| New | +$1.12M | 0.11% | 268 |
|
|
2020
Q4 | – | Sell |
-48
| Closed | -$5K | – | 1823 |
|
|
2020
Q3 | $5K | Buy |
+48
| New | +$4.78K | ﹤0.01% | 1196 |
|
|
2020
Q1 | – | Sell |
-6,017
| Closed | -$319K | – | 1566 |
|
|
2019
Q4 | $319K | Buy |
6,017
+4,046
| +205% | +$184K | 0.03% | 526 |
|
|
2019
Q3 | $77K | Buy |
1,971
+871
| +79% | +$37.8K | 0.01% | 885 |
|
|
2019
Q2 | $45K | Buy |
+1,100
| New | +$45.5K | ﹤0.01% | 923 |
|
|
2018
Q4 | – | Sell |
-414
| Closed | -$23K | – | 1560 |
|
|
2018
Q3 | $23K | Sell |
414
-208
| -33% | -$10.2K | ﹤0.01% | 1128 |
|
|
2018
Q2 | $30K | Buy |
+622
| New | +$22.7K | ﹤0.01% | 1049 |
|
|
2017
Q4 | – | Sell |
-2,917
| Closed | -$108K | – | 1576 |
|
|
2017
Q3 | $108K | Buy |
2,917
+2,352
| +416% | +$81.6K | 0.01% | 825 |
|
|
2017
Q2 | $17K | Buy |
+565
| New | +$16.4K | ﹤0.01% | 1012 |
|
|
2016
Q4 | – | Sell |
-1,242
| Closed | -$44K | – | 1445 |
|
|
2016
Q3 | $44K | Sell |
1,242
-243
| -16% | -$8.05K | ﹤0.01% | 873 |
|
|
2016
Q2 | $50K | Sell |
1,485
-1,445
| -49% | -$47K | 0.01% | 827 |
|
|
2016
Q1 | $77K | Buy |
+2,930
| New | +$85.2K | 0.01% | 790 |
|
|
2015
Q4 | – | Sell |
-7,345
| Closed | -$182K | – | 1482 |
|
|
2015
Q3 | $182K | Buy |
7,345
+4,787
| +187% | +$144K | 0.03% | 553 |
|
|
2015
Q2 | $80K | Buy |
+2,558
| New | +$82.5K | 0.01% | 711 |
|
|
2015
Q1 | – | Sell |
-1,024
| Closed | -$39K | – | 1446 |
|
|
2014
Q4 | $39K | Buy |
+1,024
| New | +$35.7K | 0.01% | 872 |
|
|
2014
Q3 | – | Sell |
-1,000
| Closed | -$33K | – | 1482 |
|
|
2014
Q2 | $33K | Buy |
+1,000
| New | +$33.4K | 0.01% | 990 |
|
Quantbot Technologies's XLRN Position: Q4 2021 in Review
Quantbot Technologies sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 8,553 shares — an estimated $1.47M sold.
Quantbot Technologies first reported a position in XLRN in Q2 2014 and held it in 16 quarters. The position peaked at $1.47M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Quantbot Technologies reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Quantbot Technologies sold 8,553 Acceleron Pharma shares in Q4 2021, an estimated $1.47M.
- Quantbot Technologies first reported a position in Acceleron Pharma in Q2 2014 and held it in 16 quarters.
- Quantbot Technologies's Acceleron Pharma position peaked at $1.47M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.